Before we present this week’s Weekend Reads, a question: Do you enjoy our weekly roundup? If so, we could really use your help. Would you consider a tax-deductible donation to support Weekend Reads, and our daily work? Thanks in advance.
The week at Retraction Watch featured:
- WHO COVID-19 library contains hundreds of papers from hijacked journals
- Will the real hottest month on record please stand up?
- Biotech co-founder faked data in NIH-funded research, says federal watchdog
- The decade-long saga capped by a $215,000 settlement with the US government
- Authors crop estimate that was off by a factor of 60 — or $3 trillion
- Meet the alleged brain surgeon who squats on domains, punks journals and listed Wolf Blitzer as a co-author
Our list of retracted or withdrawn COVID-19 papers is up to 149.
Here’s what was happening elsewhere (some of these items may be paywalled, metered access, or require free registration to read):
- “Evidence of Fraud in an Influential Field Experiment About Dishonesty.” An earlier post about work by one of the same authors. And additional reporting by BuzzFeed’s Stephanie Lee.
- “Journal citation reports and the definition of a predatory journal: The case of the Multidisciplinary Digital Publishing Institute (MDPI).” MDPI responds.
- “HHMI fires prominent biologist for sexual harassment.” [Updated as Science has updated their story.]
- “University to review plagiarism claims against ‘China’s Dr Fauci.'”
- Hottest retraction ever?
- “Backpedaling: Authors of Study on Racist Rulings Retract Their Claims Against Pennsylvania, New Jersey Judges.”
- “Didier Raoult, who promoted hydroxychloroquine treatment, may not be able to continue his research.”
- “Our findings deepen the understanding of why retraction does not stop citation and demonstrate that the vast majority of post-retraction citations in biomedicine do not document the retraction.”
- “It does strike me that part of reviewer training needs to be a frank discussion about saying ‘no’ to a review request.”
- “Biomedical Authorship: Common Misconducts and Possible Scenarios for Disputes.“
- “Dr. Death: Miracle Man.” A podcast on Paolo Macchiarini.
- “Peer review is not the best way to promote major breakthroughs,” argues Donald Braben.
- “There was an attempt to hijack a journal…” A story (with some levity) from Cabell’s International.
- “Is the process to retract fabricated randomised clinical trials in reproductive medicine working sufficiently?”
- “AI writing tools promise faster manuscripts for researchers,” but “Automation brings plagiarism risks, and software still needs human input for analysis and narrative.”
- “Family of UF grad student who died by suicide files legal claim against university.” Background here.
- “Three questions to address rigour and reproducibility concerns in your grant proposal.”
- “Researchers say a ban on preprint material citations in funding applications is a ‘remarkably stupid own-goal for Australian science.’”
- “No one goes into science because they really love bureaucracy and filling out forms.” Adds Joseph Esposito, a publishing industry consultant: “Publication in a highly ranked journal is all the transparency you need.”
- “Should old or superseded papers ever be retracted?” A reflection on that from 2012.
- “Strengthening research integrity: which topic areas should organisations focus on?”
- “African Origins of Olmec Civilization — Debunked.” Our Ivan Oransky talks about a retraction we covered in 2020.
- “Perth boy Rehan Somaweera has become one of Australia’s youngest authors of a scientific paper.”
- “This Colombian Ran A Fun-Run To Help Women Scientists Publish Their Research.”
- “[T]he legal representation for the platform [Sci-Hub] in India against the lawsuit filed by…publication companies, is the first of its kind.”
- “Small study hints that interference from bodies funding research into public-health issues such as nutrition and exercise might be more common than realized.”
- Octopus “plans to ‘provide a new ‘primary research record’ for recording and appraising research ‘as it happens.'”
- “Lack of agreement forces NICE to pause publication of ME/CFS guideline.”
- “Some students still cheat despite thinking it is illegal, international survey finds.”
- “Structural Racism and Scientific Journals—A Teachable Moment.” And updated guidance from JAMA.
- “Student Journalists Wrote About Allegations Against a Professor. Then the Articles Disappeared.”
Like Retraction Watch? You can make a one-time tax-deductible contribution or a monthly tax-deductible donation to support our work, follow us on Twitter, like us on Facebook, add us to your RSS reader, or subscribe to our daily digest. If you find a retraction that’s not in our database, you can let us know here. For comments or feedback, email us at [email protected].
“MIT and HHMI fire prominent biologist for sexual harassment.”
The Howard Hughes Medical Institute (HHMI) on Friday fired the prominent biologist David Sabatini after an investigation of his workplace behavior. Sabatini at the same time resigned from the Whitehead Institute, the non-profit research organization in Cambridge, Massachusetts where his large HHMI-supported lab was located.
Extensive pubpeer record.
https://pubpeer.com/search?q=david+sabatini
“MIT and HHMI fire prominent biologist for sexual harassment.” – pubpeer records started to appear few years ago. Unfortunately, it appears that it is a bit late effect. It has happened, i pity his staff/researchers and of course, collaborators all over the world, who should be feeling the pinch now. Honestly, this is serious.
There is a lot of suspicious data from Sabatini’s lab on pubpeer.
Luckily for Sabatini, Cell tends not to retract papers. The Cell 1994 paper which he is first author on and I assume made his career has some gel splicing issues that seem very suspicious.
https://pubpeer.com/publications/BF1E961AF625AAB497F1D0E55CBF04
A lot of the first authors on his papers have pubpeer records, and have gone on to take positions at top academic institutions —-I don’t feel sorry for them. I feel sorry for the individuals who worked in his lab who were perfectly honest.
This is what happens when you have individuals with a lot of ambition to be famous, powerful, and well-paid people in science.
The retraction by NICE of the proposed guideline on ME/ CFS because of “expert disagreement” simply adds to the evidence from the last decade that this subject is hardly worth scientific investigation. The proponents of opposing views should perhaps set up their own religions to make everyone happy.
Research Evaluation has posted a completely uninformative “expression of concern” to that article on MDPI:
https://academic.oup.com/rev/advance-article/doi/10.1093/reseval/rvab030/6360986
“The journal and publisher have been alerted to concerns about this article, and an investigation is in progress. In the interim, we alert readers that these concerns have been raised.”
The original version of this article has been retracted and a revised version has replaced it. https://academic.oup.com/rev/advance-article/doi/10.1093/reseval/rvad014/7126683